PARIS & CAMBRIDGE, England--(BUSINESS WIRE)--Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has received approval for its new consumable NOVAPrep® HQ+ orange from the China Food and Drug Administration (CFDA).
The CFDA has approved the NOVAPrep® HQ+ orange consumable which includes a new medium that better preserves the cervical samples for cytology and also for HPV testing. This follows the CFDA approval of the NOVAPrep® platform in 2014 and completes the necessary regulatory approvals for Novacyt to expand into the highly significant Chinese oncology diagnostics market.
The NOVAPrep® HQ+ orange sample preservation consumable has a number of advantages over traditional liquid based cytology consumables. Its unique design improves the sensitivity and specificity of collected samples, while the new medium provides excellent stability ensuring samples are neither damaged nor degraded prior to testing which is a significant advantage for HPV reflex testing.
Help employers find you! Check out all the jobs and post your resume.
